We are building a new standard of cancer care—one that is inclusive, data-driven, and powered by the genomic diversity of the world.
4baseCare was built on a simple truth: cancer behaves differently across populations, and yet most of the world is treated using data that doesn’t represent them. Our team is changing that by combining advanced genomics, deep clinico-genomic datasets, and AI-powered analytics to deliver personalized care for every patient.
Hitesh leads 4baseCare with a strong focus on strategic vision, innovation & execution at the intersection of Oncology, Genomics, and Technology. An entrepreneur with deep research acumen, he brings over 20 years of experience in pharma drug discovery, genomics & precision medicine, co-founding Bionivid Technology & working in high-throughput screening at Piramal Life Sciences. His ability to translate scientific insight into scalable platforms and partnerships has been central to driving innovation to make data-driven, personalized cancer care accessible across diverse populations.
Kshitij oversees strategic partnerships, real-world evidence initiatives, and patient engagement programs at 4baseCare, working closely with clinical & pharmaceutical partners to translate clinico-genomic data into meaningful insights and impact, with a key role in building collaborative ecosystems that support evidence generation, research partnerships, and improved patient access to precision oncology. An XLRI alumnus with leadership roles at Deloitte and GE, he brings strong expertise in strategy and execution. His leadership has been instrumental in expanding 4baseCare across regions.
Dr. Giridharan Periyasamy brings over 22 years of experience in cancer biology, drug discovery, and translational genomics, with a Ph.D. in Cancer Biology and Drug Discovery. He has held key scientific roles at Piramal Life Sciences, CCAMP–NCBS Bangalore, and A*STAR Singapore’s Genome Institute and Experimental Drug Discovery Centre, contributing to major programs in disease biology and therapeutic innovation
Dr. Giridharan Periyasamy brings over 22 years of experience in cancer biology, drug discovery, and translational genomics, with a Ph.D. in Cancer Biology and Drug Discovery. He has held key scientific roles at Piramal Life Sciences, CCAMP–NCBS Bangalore, and A*STAR Singapore’s Genome Institute and Experimental Drug Discovery Centre, contributing to major programs in disease biology and therapeutic innovation
Dr. Chirantan Bose is a physician-leader with over 20 years of experience at the intersection of molecular oncology, clinical diagnostics, and healthcare strategy. His work has contributed to advancing personalized cancer care, with a strong focus on liquid biopsy technologies, particularly CTCs for early cancer. His leadership spans medical oversight, quality systems, revenue cycle management, business development, and clinical operations, making him a rare blend of clinician, operator & strategist.
Praveen Jha is a seasoned life sciences and healthcare professional with over 20 years of experience spanning genomics, diagnostics, pharmaceuticals, medical devices, health nutrition, and insurance. Throughout his career, he has consistently driven organic growth across multiple organizations, taking on roles of increasing responsibility and complexity across the life sciences ecosystem.
Dr. Anjali Kulkarni is a seasoned leader in clinical oncology, healthcare technologies, and AI-driven decision systems, with deep expertise in real-world evidence and patient-centric data science. She has a strong track record of designing and implementing clinical intelligence solutions that support oncologists in improving treatment pathways and outcomes.
Dr. Rahul Kumar is a healthcare professional with extensive experience across oncology services, patient support programs, and hospital operations. At 4baseCare, he leads the PACE (Patient Care & Engagement) team, which supports patients throughout their journey—from initial touchpoint and genomic test coordination to genetic counseling, nutritional guidance, psychological support, and continuity of care.
Dr. Vidya Harini Veldore is a seasoned leader with over 19 years of experience in clinical operations, cancer genomics, and life sciences. An alumna of the prestigious Indian Institute of Science (IISc), she has held key roles at organizations such as MedGenome and HCG, bringing deep expertise in molecular biology, clinical research, and translational oncology.
Dr. Sudharshan Elangovan brings deep expertise in genomics, oncology, and regulatory science, with a strong focus on translating complex molecular insights into real-world precision medicine applications. With extensive experience interpreting genomic data and navigating the regulatory landscape, he plays a pivotal role in ensuring scientific rigor, operational excellence, and compliance across global markets.
Rahul Jha is a finance leader with over 12 years of experience in the healthcare and related industries. He specializes in financial planning, budgeting, compliance, and strategic reporting to support sustainable growth. Skilled in risk management and capital raising, he drives operational excellence by aligning finance functions with business goals.
From our early beginnings to shaping precision oncology across countries, these milestones reflect our commitment to making advanced cancer care accessible for all.
